← Eichor
Study identifier: NCT05733520 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

I-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms

Condition: Caregiver Burden · Alzheimer Disease  ·  Sponsor: Indiana University

PhaseNA
Planned participants184
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This study is a randomized, controlled trial (RCT) to evaluate the effect of Brain CareNotes (a mobile health application) on the burden experienced by unpaid caregivers of patients with dementia and on the behavioral and psychological symptoms of dementia (BPSD) displayed by care recipients. Over 39 months, the trial will enroll 184 caregivers of community-dwelling patients diagnosed with Alzheimer's disease or a related dementia (ADRD). Caregivers will be randomized to use the Brain CareNotes app or an attention control education-only app for 12 months, with usage reminders.

This description comes directly from the study's public registry record.

Talk to the study team

Miriam J Rodriguez, PhD  ·  (812) 856-1661  ·  mijrodri@iu.edu

Jordan R Hill, PhD  ·  812-856-5032  ·  jrh6@iu.edu

Always discuss trial participation with your own doctor first.

Locations (2)

IU HealthIndianapolis, Indiana, United StatesRecruiting
Community Health NetworkIndianapolis, Indiana, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05733520